The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-4-((3-chlorophenyl)sulfamoyl)-N-propylbenzamide ID: ALA5186508
PubChem CID: 126970809
Max Phase: Preclinical
Molecular Formula: C23H23ClN2O3S
Molecular Weight: 442.97
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2cccc(Cl)c2)cc1
Standard InChI: InChI=1S/C23H23ClN2O3S/c1-2-15-26(17-18-7-4-3-5-8-18)23(27)19-11-13-22(14-12-19)30(28,29)25-21-10-6-9-20(24)16-21/h3-14,16,25H,2,15,17H2,1H3
Standard InChI Key: VMGWOAVOASXXIH-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
-1.0692 1.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3546 1.4443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3572 1.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3572 0.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3528 -0.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0692 0.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7838 -0.2090 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.4985 0.2035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2131 -0.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2134 -1.0342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9262 -1.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6411 -1.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6426 -0.2111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9308 0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1972 -0.9250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3720 -0.9250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0718 1.4450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0718 2.2701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7865 1.0324 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5011 1.4450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2157 1.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9305 1.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6426 1.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6426 0.2073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9323 -0.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2157 0.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7865 0.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9262 -2.2701 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.0718 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0718 -1.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
7 15 2 0
7 16 2 0
3 17 1 0
17 18 2 0
17 19 1 0
19 20 1 0
20 21 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
19 27 1 0
11 28 1 0
27 29 1 0
29 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 442.97Molecular Weight (Monoisotopic): 442.1118AlogP: 5.19#Rotatable Bonds: 8Polar Surface Area: 66.48Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.51CX Basic pKa: ┄CX LogP: 4.97CX LogD: 4.76Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.52Np Likeness Score: -2.04
References 1. Hanke T, Mathea S, Woortman J, Salah E, Berger BT, Tumber A, Kashima R, Hata A, Kuster B, Müller S, Knapp S.. (2022) Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes., 65 (19.0): [PMID:36136092 ] [10.1021/acs.jmedchem.2c01106 ] 2. Collins R, Lee H, Jones DH, Elkins JM, Gillespie JA, Thomas C, Baldwin AG, Jones K, Waters L, Paine M, Atack JR, Ward SE, Grubisha O, Foley DW.. (2022) Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity., 65 (20.0): [PMID:36205722 ] [10.1021/acs.jmedchem.2c00751 ]